These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 35443502)

  • 1. Association of Inflammatory markers with Covid-19 Outcome among Hospitalized adult Patients.
    Bohra GK; Bhatia PK; Khichar S; Garg MK; Sharma P
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Inflammatory Markers with COVID-19 Outcome among Hospitalized Patients: Experience from a Tertiary Healthcare Center in Western India.
    Sakthivadivel V; Bohra GK; Maithilikarpagaselvi N; Khichar S; Meena M; Palanisamy N; Gaur A; Garg MK
    Maedica (Bucur); 2021 Dec; 16(4):620-627. PubMed ID: 35261664
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of inflammatory indices in the outcome of COVID-19 cancer patients.
    Nooh HA; Abdellateif MS; Refaat L; Kandeel EZ; Bayoumi A; Samra M; Khafagy M
    Med Oncol; 2021 Nov; 39(1):6. PubMed ID: 34748094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the Impact of Inflammatory Markers and CT Severity Score on Disease Severity of COVID-19 Patients Admitted to ICU at a Tertiary Hospital.
    Kurri N; Tyagi B; Singhal E; Gupta N; Agarwal AK; Gupta V; Rai G; Bindra MS
    J Assoc Physicians India; 2021 Jun; 69(6):11-12. PubMed ID: 34472783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Inflammatory Markers with Disease Severity and Outcome in Covid-19 Patients.
    Gjuzelova AA; Nakova VV; Nanovic Z; Metodieva M; Stojkoska AJ; Camurovski N; Mitreski V; Krstevska SS
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2023 Mar; 44(1):89-95. PubMed ID: 36987769
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of simple and cost-effective immuno- haematological markers to predict outcome in hospitalized severe COVID-19 patients, with a focus on diabetes mellitus - A retrospective study in Andhra Pradesh, India.
    Ramesh J; Reddy SLS; Rajesh M; Varghese J
    Diabetes Metab Syndr; 2021; 15(3):739-745. PubMed ID: 33819728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidities influence the predictive power of hematological markers for mortality in hospitalized COVID-19 patients.
    Parthasarathi A; Basavaraja CK; Arunachala S; Chandran S; Venkataraman H; Satheesh A; Mahesh PA
    Adv Respir Med; 2022 Jan; ():. PubMed ID: 35099049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients.
    Abdelhady SA; Rageh F; Ahmed SS; Al-Touny SA; Riad E; Elhoseeny MM; Khalifa AA; Salim A; Farghly MI; Elgamal R
    Egypt J Immunol; 2022 Apr; 29(2):57-67. PubMed ID: 35436055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
    Yang M; Chen X; Xu Y
    Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Study of De Ritis (Ast/ Alt) Ratio in Comparision with Other Parameters for Predicting Poor Prognosis in Covid 19 Patients.
    A Y; R V
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of C-reactive protein as a prognostic marker in COVID-19.
    Stringer D; Braude P; Myint PK; Evans L; Collins JT; Verduri A; Quinn TJ; Vilches-Moraga A; Stechman MJ; Pearce L; Moug S; McCarthy K; Hewitt J; Carter B;
    Int J Epidemiol; 2021 May; 50(2):420-429. PubMed ID: 33683344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the prognostic values of inflammation markers in patients with acute pancreatitis: a retrospective cohort study.
    Li Y; Zhao Y; Feng L; Guo R
    BMJ Open; 2017 Mar; 7(3):e013206. PubMed ID: 28348184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematological parameters predicting severity and mortality in COVID-19 patients of Pakistan: a retrospective comparative analysis.
    Asghar MS; Khan NA; Haider Kazmi SJ; Ahmed A; Hassan M; Jawed R; Akram M; Rasheed U; Memon GM; Ahmed MU; Tahniyat U; Tirmizi SB
    J Community Hosp Intern Med Perspect; 2020 Oct; 10(6):514-520. PubMed ID: 33194120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor Prognostic Biochemical Markers Predicting Fatalities Caused by COVID-19: A Retrospective Observational Study From a Developing Country.
    Asghar MS; Haider Kazmi SJ; Khan NA; Akram M; Hassan M; Rasheed U; Ahmed Khan S
    Cureus; 2020 Aug; 12(8):e9575. PubMed ID: 32913691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19.
    Pink I; Raupach D; Fuge J; Vonberg RP; Hoeper MM; Welte T; Rademacher J
    Infection; 2021 Oct; 49(5):935-943. PubMed ID: 34021897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
    Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
    Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.
    Yao C; Liu X; Tang Z
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2285-2290. PubMed ID: 28814856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of procalcitonin on predicting the severity and prognosis in patients with early ARDS: a prospective observation study].
    Yu Z; Ji M; Hu X; Yan J; Jin Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jan; 29(1):34-38. PubMed ID: 28459401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers.
    Akamine T; Takada K; Toyokawa G; Kinoshita F; Matsubara T; Kozuma Y; Haratake N; Takamori S; Hirai F; Tagawa T; Okamoto T; Yoneshima Y; Okamoto I; Shimokawa M; Oda Y; Nakanishi Y; Maehara Y
    Surg Oncol; 2018 Mar; 27(1):88-94. PubMed ID: 29549910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation parameters predict fatal outcome in male COVID-19 patients in a low case-fatality area - a population-based registry study.
    Forsblom E; Helanne H; Kortela E; Silén S; Meretoja A; Järvinen A
    Infect Dis (Lond); 2022 Aug; 54(8):558-571. PubMed ID: 35353030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.